Efficacy and safety of hybutimibe in combination with atorvastatin for treatment of hypercholesteremia among patients with atherosclerotic cardiovascular disease risk equivalent: A multicenter, randomized, double-blinded phase III study

Efficacy and safety of hybutimibe in combination with atorvastatin for treatment of hypercholesteremia among patients with atherosclerotic cardiovascular disease risk equivalent: A multicenter, randomized, double-blinded phase III study

BackgroundTo evaluate the safety and efficacy of hybutimibe plus atorvastatin for lipid control in hypercholesterolemia patients with atherosclerotic cardiovascular disease risk equivalent.MethodsIn this double-blind phase III study, we 1:1 randomly assigned 255 hypercholesterolemia patients with at...

Full description

Bibliographic Details
Main Authors: Litong Qi, Jiyan Chen, Xiaodong Li, Xiaoyong Qi, Chunhua Ding, Xiaoping Chen, Xiang Gu, Wenliang Xiao, Shuiping Zhao, Yugang Dong, Mingqi Zheng, Kai Huang, Liangqiu Tang, Xiaomei Guo, Fang Wang, Guosheng Fu, Junxia Li, Yong Huo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
atherosclerotic cardiovascular disease risk equivalent
lipid profile
hybutimibe
atorvastatin
randomized controlled trial
cholesterol-absorption inhibitor
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.888604/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.888604/full

Similar Items